What should you know about Sinopharm vaccine and mRNA vaccines?

Vaccine technology describes how the immune system is shown a target. Sinopharm uses inactivated viral material that cannot reproduce, while an mRNA Vaccine provides temporary genetic instructions that cells use to make a harmless target protein. The immune system then practises recognising that target. The mRNA instructions are broken down after use and do not change a person's genetic code. These platforms are not interchangeable names, and a vaccination record should identify the product received. Protection, authorised schedules and advice can change, so a clinician should interpret the record in its current context.

Keep the vaccine name, date and dose information together, and show it before arranging another dose. Tell the vaccinator about previous reactions, severe allergies, pregnancy, immune-system conditions, current illness and medicines. Do not assume an mRNA dose can simply replace a Sinopharm dose; the correct schedule depends on local guidance and your history. After vaccination, remain where staff advise for observation, follow their aftercare instructions and use fluids and rest for mild short-lived effects. Ask before mixing products or timing an additional dose.

Seek emergency help for trouble breathing, collapse, widespread hives, or swelling of the lips, tongue or throat after vaccination. Contact a clinician for severe or persistent symptoms, chest pain, fainting, or a racing heartbeat. A mild sore arm, tiredness or fever can occur, but worsening illness deserves assessment rather than being attributed automatically to the vaccine.

Ask which platform your previous dose used, which product is recommended next, and whether the interval fits your record. Ask what side effects to expect, which symptoms require urgent help, and whether your medical history changes the plan.